Oncological scintigraphy in dogs with 99mTechnetium MIBI and DMSA(V)--two case reports.
Oncological scintigraphy is described in two dogs with malignant lymphoma and malignant schwannoma, respectively. The distribution of the radiopharmaceuticals could be visualized for the purpose of detection of neoplasia and eventual metastases, and to evaluate the effectivity of therapy. It is concluded that 99mTechnetium MIBI and 99mTc DMSA (V) scintigraphy is useful for the detection of soft tissue malignancy in dogs.
Balogh
L
L
Department of Applied Radioisotopes, Fodor József National Center of Health, Nation F.J.C. Researach Institute of Radiobiology and Radiohygiene, Budapest, Hungary.
Andócs
G
G
Perge
E
E
Vajdovich
P
P
Thuróczy
J
J
Láng
J
J
Jánoki
G A
GA
D000818:Animals; D004283:Dog Diseases / Q000000981:diagnostic imaging*; D004285:Dogs; D005260:Female; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging / Q000662:veterinary*; D008223:Lymphoma / Q000000981:diagnostic imaging / Q000662:veterinary*; D008297:Male; D009442:Neurilemmoma / Q000000981:diagnostic imaging / Q000662:veterinary*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D017256:Technetium Tc 99m Sestamibi
D019275:Radiopharmaceuticals; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D017256:Technetium Tc 99m Sestamibi